Compare CRDO & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDO | ALC |
|---|---|---|
| Founded | 2008 | 1945 |
| Country | Cayman Islands | Switzerland |
| Employees | N/A | N/A |
| Industry | Semiconductors | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2B | 39.0B |
| IPO Year | 2022 | N/A |
| Metric | CRDO | ALC |
|---|---|---|
| Price | $148.89 | $79.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $189.50 | $88.29 |
| AVG Volume (30 Days) | ★ 5.2M | 1.1M |
| Earning Date | 03-03-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 0.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.11 | ★ 2.10 |
| Revenue | $796,128,000.00 | ★ $10,185,000,000.00 |
| Revenue This Year | $177.26 | $5.76 |
| Revenue Next Year | $37.90 | $7.24 |
| P/E Ratio | $145.17 | ★ $37.74 |
| Revenue Growth | ★ 224.17 | 4.34 |
| 52 Week Low | $29.09 | $71.55 |
| 52 Week High | $213.80 | $99.20 |
| Indicator | CRDO | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 51.94 | 49.47 |
| Support Level | $124.70 | $77.89 |
| Resistance Level | $164.74 | $81.65 |
| Average True Range (ATR) | 9.61 | 1.46 |
| MACD | 2.06 | -0.16 |
| Stochastic Oscillator | 69.23 | 47.05 |
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.